Sysmex (OTCMKTS:SSMXY) Releases Quarterly Earnings Results, Misses Expectations By $0.04 EPS

Sysmex (OTCMKTS:SSMXYGet Free Report) issued its quarterly earnings results on Friday. The company reported $0.20 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.24 by ($0.04), MarketWatch Earnings reports. Sysmex had a return on equity of 11.02% and a net margin of 10.25%. The business had revenue of $770.84 million during the quarter.

Sysmex Stock Down 1.0 %

Shares of OTCMKTS:SSMXY opened at $25.68 on Monday. The stock’s 50-day moving average price is $27.40 and its two-hundred day moving average price is $26.66. The company has a current ratio of 2.97, a quick ratio of 2.19 and a debt-to-equity ratio of 0.04. Sysmex has a 12-month low of $22.18 and a 12-month high of $36.57. The firm has a market cap of $10.77 billion, a price-to-earnings ratio of 33.79 and a beta of 0.68.

Sysmex Company Profile

(Get Free Report)

Sysmex Corporation engages in the development, manufacture, and sale of diagnostic instruments, reagents, and related software in Japan. It offers three-part and five-part white blood cell differentiation instruments for use in hematology; and transport systems for high-volume testing in labs. The company also provides automated urine particle analyzers; automated blood coagulation analyzers; automated immunochemistry systems, which perform assays on minute sample quantities, as well as reagents to test for infectious disease and tumor markers; and flow cytometers to perform analysis in diagnosing leukemia, malignant lymphoma, and HIV/AIDS.

Read More

Earnings History for Sysmex (OTCMKTS:SSMXY)

Receive News & Ratings for Sysmex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sysmex and related companies with MarketBeat.com's FREE daily email newsletter.